[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:cerebral-amyloid-angiopathy":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":21,"states":22},"Cerebral Amyloid Angiopathy",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06393712","A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy",[11],"Phase 2","RECRUITING","2026-08-26T02:15:45.413021Z","2026-05-05T02:43:28.743716Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT05709314","A Study of AMDX-2011P in Participants With CAA",[11],"2026-08-26T02:19:00.742020Z","2026-05-05T02:35:31.874122Z",[],[]]